These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
þ
|
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
o
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
Delaware
|
04-3536131
|
|
(State or Other Jurisdiction of Incorporation or Organization)
|
(IRS Employer Identification No.)
|
|
45 First Avenue
|
|
|
Waltham, Massachusetts
|
02451
|
|
(Address of Principal Executive Offices)
|
(Zip Code)
|
|
Title of each class
|
Name of each exchange on which registered
|
|
Common Stock, $0.001 par value
|
N/A
|
|
Large accelerated filer
o
|
Accelerated filer
o
|
|
Non –accelerated filer
o
|
Smaller reporting company
x
|
|
|
|
|
|
|
|
Item 1A.
|
Risk Factors.
|
|
|
Item 1B.
|
Unresolved Staff Comments.
|
|
|
Item 2.
|
Properties.
|
|
|
Item 3.
|
Legal Proceedings.
|
|
|
Item 4.
|
Mine Safety Disclosures.
|
|
|
|
|
|
|
PART II
|
||
|
|
|
|
|
Item 5.
|
Market for the Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.
|
|
|
Item 6.
|
Selected Financial Data.
|
|
|
Item 7.
|
Management’s Discussion and Analysis of Financial Condition and Results of Operations.
|
|
|
Item 7A.
|
Quantitative and Qualitative Disclosures About Market Risk.
|
|
|
Item 8.
|
Financial Statements and Supplementary Data.
|
|
|
Item 9.
|
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.
|
|
|
Item 9A.
|
Controls and Procedures.
|
|
|
Item 9B.
|
Other Information.
|
|
|
|
|
|
|
PART III
|
||
|
Item 10.
|
Directors, Executive Officers and Corporate Governance.
|
|
|
Item 11.
|
Executive Compensation.
|
|
|
Item 12.
|
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.
|
|
|
Item 13.
|
Certain Relationships and Related Transactions, and Director Independence.
|
|
|
Item 14.
|
Principal Accountant Fees and Services.
|
|
|
|
|
|
|
PART IV
|
||
|
|
|
|
|
Item 15.
|
Exhibits and Financial Statement Schedules.
|
|
|
•
|
Cogeneration units that supply electricity and hot water;
|
|
•
|
Chillers that provide air-conditioning and hot water; and
|
|
•
|
High-efficiency water heaters.
|
|
•
|
Dramatically increased fuel efficiency;
|
|
•
|
Reduced emissions of carbon dioxide (CO
2
) and other pollutants;
|
|
•
|
Cost savings for the energy consumer;
|
|
•
|
Reduced need for transmission and distribution networks; and
|
|
•
|
Beneficial use of local energy resources, providing a transition to a low-carbon future.
|
|
System Size (MW)
|
|
<1
|
|
1 - 4.9
|
|
5 – 19.9
|
|
>20
|
||||
|
2009 Inventory (MW)
|
|
200
|
|
|
350
|
|
|
750
|
|
|
7,900
|
|
|
New Potential Through 2029 (MW)
|
|
1,138
|
|
|
1,279
|
|
|
764
|
|
|
3,015
|
|
|
Relative Growth Potential (%)
|
|
569
|
%
|
|
365
|
%
|
|
102
|
%
|
|
38
|
%
|
|
•
|
Changing outlook for natural gas supply and pricing as a result of shale exploration;
|
|
•
|
Growing state policymaking and support; and
|
|
•
|
Changing market conditions for the power and industrial sectors such as ageing power plants and boilers, as well as more strict air regulations.
|
|
•
|
General Motors Company — supplier of raw materials pursuant to a supplier agreement since the development of our cogeneration product in the early 1960s.
|
|
•
|
Sacramento Municipal Utility District — has provided test sites for the Company since 2010.
|
|
•
|
Southern California Gas Company and San Diego Gas & Electric Company, each a Sempra Energy subsidiary — have granted us research and development contracts since 2004.
|
|
•
|
Lawrence Berkeley National Laboratory — research and development contracts since 2005.
|
|
•
|
Consortium for Electric Reliability Technology Solutions — research and development contracts and provided a test site to the Company since 2005.
|
|
•
|
California Energy Commission — research and development contracts from 2004 until March 2013.
|
|
•
|
The AVL California Technology Center — support role in performance of research and development contracts as well as internal research and development on our emission control system from August 2009 to November 2011.
|
|
|
|
|
|
Fuel
|
CO
2
emissions, lbs/million Btu
|
|
|
Natural Gas
|
116.7
|
|
|
Distillate Oil
|
160.9
|
|
|
Coal
|
206.7
|
|
|
(1)
|
Average U.S. Powerplant CO
2
emission rate of 1,293 (lb/MWh) from USEPA eGrid 2010.
|
|
(2)
|
Coal Combined Cycle emissions based upon 50% efficiency (assumed to be the same as Natural Gas) and coal CO
2
emission rate from EPA website.
|
|
(3)
|
“Best in Class” Natural Gas combined cycle plant emissions based upon 50% efficiency. (Northwest Power Planning Council “Natural Gas Combined-cycle Gas Turbine Power Plants, August 2002).
|
|
(4)
|
Fuel Cell and Microturbine emissions based upon data listed in the ICF International Combined Heat and Power Market Assessment, April 2010.
|
|
(1)
|
Based upon an annual output of 100 kW and 670,000 Btu/hr of hot water.
|
|
(2)
|
Average U.S. powerplant NOx emission rate of 1.7717 lb/MWh from (USEPA eGrid 2010), CO data not available.
|
|
(3)
|
Gas boiler efficiency of 78% (www.eia.gov) with emissions of 20 ppm NOx @ 3% O2 (California Regulation SCAQMD Rule 1146.2) and 50 ppmvCO @ 3% O2 (California Regulation SCAQMD BACT).
|
|
(1)
|
Tecogen emissions based upon actual third party source test data.
|
|
(2)
|
Microturbine and Fuel Cell NOx data from California Energy Commission, Combined Heat and Power Market Assessment 2010, by ICF international.
|
|
(3)
|
Stationary engine BACT as defined by SCAQMD.
|
|
(4)
|
Limits represent CARB 2007 emission standard for Distributed Generation with a 60% (HHV) Overall Efficiency credit.
|
|
(5)
|
CO data not available for microturbine and fuel cell.
|
|
•
|
The
InVerde
® and TECOGEN® cogeneration units;
|
|
•
|
TECOCHILL® chillers;
|
|
•
|
Ilios high-efficiency water heaters; and
|
|
•
|
Ultra
low-emissions technology.
|
|
1.
|
Third-party laboratory verification.
The AVL California Technology Center, a long-standing research and technology partner with the international automotive industry, confirmed our results in their state-of-the-art dynamometer test cell, which was outfitted with sophisticated emissions measurement equipment.
|
|
2.
|
Verifying longevity and reliability in the field.
We did so by equipping one of our TECOGEN 75-kW units, already operating at a customer location in Southern California, with the Ultra low-emissions technology and a device to monitor emissions continuously. To date, the Ultra low-emissions system has operated successfully for more than 25,000 hours (approximately 3 1/2 years) and has consistently complied with California’s emission standards. This field test is ongoing.
|
|
3.
|
Additional independent tests.
During the field test, two companies licensed in California to test emissions each verified our results at different times. The results from one of these tests (obtained in August 2011) enabled us to qualify for New Jersey’s fast-track permitting. Virtually every state nationwide requires some kind of permit related to local air quality, but New Jersey allows an exemption for systems such as ours that demonstrate superior emissions performance. This certification was granted in November 2011, and since then we have sold Ultra low-emissions systems to several customers.
|
|
|
December 31, 2013
|
|
December 31, 2012
|
||||
|
Products:
|
|
|
|
|
|
||
|
Cogeneration
|
$
|
5,199,649
|
|
|
$
|
5,791,412
|
|
|
Chiller
|
1,146,401
|
|
|
1,661,810
|
|
||
|
Total Product Revenue
|
6,346,050
|
|
|
7,453,222
|
|
||
|
Services
|
7,071,388
|
|
|
7,089,491
|
|
||
|
Installations
|
2,432,431
|
|
|
711,259
|
|
||
|
Total Service Revenue
|
9,503,819
|
|
|
7,800,750
|
|
||
|
Total Revenue
|
$
|
15,849,869
|
|
|
$
|
15,253,972
|
|
|
•
|
Our CHP products provide an efficient on-site solution to power generation as the market seeks cost savings and clean alternatives to centralized grid power.
|
|
•
|
Our CHP products are all standard, modular units that come pre-packaged from the factory to simplify installation and grid connection. The systems are supported in the field by a nationwide network of experienced professional staff. Standardized CHP units, as opposed to custom-designed systems, achieve lower cost, better quality control, higher reliability, and easier service. Emission controls are integrated, and complete system warranty and maintenance are available.
|
|
•
|
Our
Ultra
low-emissions technology eliminates the air quality concerns associated with engines. Our units comply with the most rigorous air quality regulations, including California’s.
|
|
•
|
Our cogeneration systems and chillers use standard, well-proven equipment made by reputable, well-established manufacturers. These components include rugged automotive engines, certified inverters, commercial generators, and conventional compressors. Certain key components are proprietary and have patent protection. Most notably, all control software is either proprietary (and copyright protected) or under an exclusive license agreement. Suppliers of the
InVerde `s
inverter and generator hold certain related patent protection.
|
|
•
|
All of our CHP products can be designed for installation of multiple units at a single site, depending on the customer’s particular needs. This enhances the ability of our products to meet the building’s varying demand for electricity, heat, and/or air conditioning throughout the day and from season to season. Also, multiple units operate more efficiently throughout the range of a customer’s high and low energy requirements.
|
|
•
|
Our
InVerde
product is opening new market opportunities and expanding our reach to customers beyond our traditional market segments. The
InVerde`s
black-start feature addresses a crucial demand from customers concerned about utility blackouts and brownouts, natural disasters, security threats, and antiquated grid infrastructure. The
InVerde
also provides premium-quality power, which is required by operators of computer server farms and precision instrumentation, for example.
|
|
•
|
The
InVerde
overcomes barriers related to grid interconnection, since the product is UL-certified as utility-safe. In microgrids,
InVerde
units can help prevent brownouts by maximizing their power output when utilities approach peak capacity. Unlike standby diesel generators, the
InVerde
can operate without hourly limits because its emissions are so low, and it can serve as a stable anchor in hybrid microgrids that incorporate solar power.
|
|
•
|
Our extensive use of standardized components lets us manufacture CHP products at competitive prices, even at relatively low production volumes. Proven, well-understood hardware increases the reliability and durability of the equipment and reduces the cost of servicing in the field. We are also able to minimize spare parts inventories and simplify training requirements.
|
|
•
|
The Ilios heat pump water heater roughly doubles the efficiency of conventional water heating systems. The Ilios heat pump targets a large international market that is characterized by heavy, year-round use. This will increase fuel savings and maximize return on investment for the customer. Also, such applications are mostly central heating and cooling systems, rather than units distributed throughout the building, so it is easier to integrate new equipment. The heat pump water heater product competes only against other gas-fueled water heaters, which could expand our market beyond areas with high electric rates, and regulatory issues should be minimal.
|
|
|
|
Microturbine 50 – 500 kW
|
|
Fuel Cell
50 – 500 kW
|
|
Generic Engine
100 kW
|
|
Installed Costs, $/kW
|
|
2,739
|
|
6,310
|
|
2,210
|
|
O&M Costs, $/kWh
|
|
0.022
|
|
0.038
|
|
0.020
|
|
Electric Efficiency, %
|
|
25.2%
|
|
36.0%
|
|
28.4%
|
|
Thermal Output, Btu/kWh
|
|
6,277
|
|
2,923
|
|
6,100
|
|
Overall Efficiency, %
|
|
72%
|
|
67%
|
|
79%
|
|
•
|
8,578,704: “Assembly and method for reducing nitrogen oxides, carbon monoxide, and hydrocarbons in exhausts of internal combustion engines.” This patent, granted in November 2013, is for the
Ultra
emission system applicable to all our products.
|
|
•
|
7,239,034: “Engine driven power inverter system with cogeneration”. This patent, granted in July 2007, pertains to the utilization of an engine-driven CHP module combined with an inverter and applies to our
InVerde
product specifically.
|
|
•
|
7,243,017: “Method for controlling internal combustion engine emissions”. This patent, granted in July 2007, applies to the specific algorithms used in our engine controller for metering the fuel usage to obtain the correct combustion mixture. It applies to most of our engines.
|
|
•
|
Product safety certifications and interconnection requirements;
|
|
•
|
Air pollution regulations, which govern the emissions allowed in engine exhaust;
|
|
•
|
State and federal incentives for CHP technology; and
|
|
•
|
Electric utility pricing and related regulations.
|
|
•
|
results and timing of our product development;
|
|
•
|
results of the development of our competitors’ products;
|
|
•
|
regulatory actions with respect to our products or our competitors’ products;
|
|
•
|
actual or anticipated fluctuations in our financial condition and operating results;
|
|
•
|
actual or anticipated changes in our growth rate relative to our competitors;
|
|
•
|
actual or anticipated fluctuations in our competitors’ operating results or changes in their growth rate;
|
|
•
|
competition from existing products or new products that may emerge;
|
|
•
|
announcements by us or our competitors of significant acquisitions, strategic partnerships, joint ventures, collaborations, or capital commitments;
|
|
•
|
issuance of new or updated research or reports by securities analysts;
|
|
•
|
fluctuations in the valuation of companies perceived by investors to be comparable to us;
|
|
•
|
share price and volume fluctuations attributable to inconsistent trading volume levels of our shares;
|
|
•
|
additions or departures of key management or personnel;
|
|
•
|
disputes or other developments related to proprietary rights, including patents, litigation matters, and our ability to obtain, maintain, defend or enforce proprietary rights relating to our products and technologies;
|
|
•
|
announcement or expectation of additional financing efforts;
|
|
•
|
sales of our Common Stock by us, our insiders, or our other stockholders; and
|
|
•
|
general economic and market conditions.
|
|
•
|
have an auditor report on our internal controls over financial reporting pursuant to Section 404(b) of the Sarbanes-Oxley Act;
|
|
•
|
comply with any requirement that may be adopted by the Public Company Accounting Oversight Board regarding mandatory audit firm rotation or a supplement to the auditor’s report providing additional information about the audit and the financial statements (i.e., an auditor discussion and analysis);
|
|
•
|
submit certain executive compensation matters to shareholder non-binding advisory votes;
|
|
•
|
submit for shareholder approval golden parachute payments not previously approved; and
|
|
•
|
disclose certain executive compensation related items such as the correlation between executive compensation and financial performance and comparisons of the Chief Executive Officer’s compensation to median employee compensation, when such disclosure requirements are adopted.
|
|
Item 5.
|
Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.
|
|
Name
|
Age
|
Position(s)
|
|
|
|
|
|
Angelina M. Galiteva (1)(2)
|
47
|
Chairperson of the Board and Director
|
|
John N. Hatsopoulos
|
79
|
Chief Executive Officer and Director
|
|
Robert A. Panora
|
59
|
Chief Operating Officer and President
|
|
Bonnie J. Brown
|
51
|
Chief Financial Officer, Treasurer and Secretary
|
|
George N. Hatsopoulos
|
87
|
Director
|
|
Dr. Ahmed F. Ghoniem (1)(2)(3)
|
62
|
Director
|
|
Charles T. Maxwell (1)(3)
|
82
|
Director
|
|
Joseph E. Aoun (2)(3)
|
60
|
Director
|
|
|
|
|
|
(1) Member of Audit Committee
|
||
|
(2) Member of Compensation Committee
|
||
|
(3) Member of the Nominating and Governance Committee
|
||
|
•
|
the executive officer’s skills and experience;
|
|
•
|
the particular importance of the executive officer’s position to us;
|
|
•
|
the executive officer’s individual performance;
|
|
•
|
the executive officer’s growth in his or her position; and
|
|
•
|
base salaries for comparable positions within our Company and at other companies.
|
|
Name and principal position
|
Year
|
Salary ($)
|
Bonus ($)
|
Stock awards ($)
|
Option awards ($)(1)
|
All other compensation ($)
|
Total ($)
|
||||||
|
|
|
|
|
|
|
|
|
||||||
|
John N. Hatsopoulos
|
2013
|
1
|
|
—
|
|
—
|
|
—
|
|
—
|
|
1
|
|
|
Chief Executive Officer
|
2012
|
1
|
|
—
|
|
—
|
|
—
|
|
—
|
|
1
|
|
|
(Principal Executive Officer)
|
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
||||||
|
Robert A. Panora (2)
|
2013
|
163,770
|
|
—
|
|
—
|
|
—
|
|
1,032
|
|
164,802
|
|
|
Chief Operating Officer and President
|
2012
|
163,770
|
|
—
|
|
—
|
|
—
|
|
1,032
|
|
164,802
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Bonnie J. Brown (3)
|
2013
|
156,000
|
|
—
|
|
—
|
|
—
|
|
360
|
|
156,360
|
|
|
Chief Financial Officer, Treasurer and Secretary
|
2012
|
156,000
|
|
—
|
|
—
|
|
—
|
|
360
|
|
156,360
|
|
|
(Principal Financial Officer)
|
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
||||||
|
Anthony S. Loumidis (4)
|
|
|
|
|
|
|
|
||||||
|
Former Vice President and Treasurer
|
2012
|
25,091
|
|
—
|
|
—
|
|
—
|
|
—
|
|
25,091
|
|
|
(1)
|
The amounts in the “Stock Option Awards” column reflect the aggregate grant date fair value of the awards computed in accordance with FASB ASC Topic 718. The assumptions used by us with respect to the valuation of stock and option awards are set forth in
Note 10 – Stockholders’ equity
to our financial statements included elsewhere in this registration statement.
|
|
(2)
|
Includes group life insurance of $1,032 for
2013
and
2012
, respectively.
|
|
(3)
|
Includes group life insurance of $360 for
2013
and
2012
.
|
|
(4)
|
Mr. Loumidis resigned as Vice President and Treasurer of the Company effective December 31, 2012.
|
|
|
|
Option awards
|
|
Stock awards
|
||||||||||||||
|
Name
|
|
Number of
securities underlying unexercised options (#)exercisable |
|
Number of
securities underlying unexercised options (#)unexercisable |
|
Option
exercise
price ($)
|
|
Option
expiration
date
|
|
Number of
shares of stock that have
not vested (#)
|
|
Market value
of shares of stock that have
not vested ($)
(1)
|
||||||
|
John N. Hatsopoulos
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
Robert A. Panora
(2)(3)
|
|
62,500
|
|
|
62,500
|
|
|
2.60
|
|
|
2/14/2021
|
|
|
138,350
|
|
|
622,575
|
|
|
Bonnie J. Brown
(4)(5)
|
|
25,000
|
|
|
—
|
|
|
1.20
|
|
|
2/13/2015
|
|
|
12,500
|
|
|
56,250
|
|
|
Bonnie J. Brown
(6)
|
|
50,000
|
|
|
—
|
|
|
2.00
|
|
|
3/11/2019
|
|
|
—
|
|
|
—
|
|
|
Bonnie J. Brown
(7)
|
|
18,750
|
|
|
6,250
|
|
|
2.60
|
|
|
2/18/2020
|
|
|
—
|
|
|
—
|
|
|
(1)
|
Market value of shares of stock that have not vested is computed on the last private placement price of the Company’s Common Stock on January 17, 2014, which was $4.50 per share.
|
|
(2)
|
Includes stock option award granted on February 15, 2011, with 25% of the shares vesting on February 15, 2012 and then an additional 25% of the shares vesting on each of the subsequent three anniversaries, subject to Mr. Panora’s continued employment and subject to acceleration of vesting upon a change in control.
|
|
(3)
|
Includes 138,350 shares of restricted Common Stock at a purchase price of $.001 per share granted on December 4, 2006, with 100% of the shares vesting one year after the Company’s initial public offering, subject to acceleration of vesting upon a change in control prior to a termination event.
|
|
(4)
|
Includes stock option award granted on February 13, 2008, with 25% of the shares vesting on February 13, 2009 and then an additional 25% of the shares vesting on each of the subsequent three anniversaries, subject to Ms. Brown’s continued employment and subject to acceleration of vesting upon a change in control.
|
|
(5)
|
Includes 12,500 shares of restricted Common Stock at a purchase price of $.004 per share granted on December 13, 2006, with 100% of the shares vesting one year after the Company’s initial public offering, subject to acceleration of vesting upon a change in control prior to a termination event.
|
|
(6)
|
Includes stock option award granted on March 11, 2009, with 25% of the shares vesting on March 11, 2010 and then an additional 25% of the shares vesting on each of the subsequent three anniversaries, subject to Ms. Brown’s continued employment and subject to acceleration of vesting upon a change in control.
|
|
(7)
|
Includes stock option award granted on February 28, 2010, with 25% of the shares vesting on February 28, 2011 and then an additional 25% of the shares vesting on each of the subsequent three anniversaries, subject to Ms. Brown’s continued employment and subject to acceleration of vesting upon a change in control.
|
|
Name
|
Fees earned or paid in cash ($)
|
Stock awards ($)
|
Option awards ($)
|
All other compensation ($)
|
Total ($)
|
|||||
|
|
|
|
|
|
|
|||||
|
Angelina M. Galiteva
|
1,500
|
|
—
|
|
—
|
|
—
|
|
1,500
|
|
|
John N. Hatsopoulos
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
|
George N. Hatsopoulos
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
|
Ahmed F. Ghoniem
|
500
|
|
—
|
|
—
|
|
—
|
|
500
|
|
|
Charles T. Maxwell
|
1,000
|
|
—
|
|
—
|
|
—
|
|
1,000
|
|
|
Joseph E. Aoun
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
|
|
|
Option awards
|
|
Stock awards
|
||||||||||||||
|
Name
|
|
Number of
securities underlying unexercised options (#)exercisable |
|
Number of
securities
underlying
unexercised
options (#)
unexercisable
|
|
Option
exercise
price ($)
|
|
Option
expiration
date
|
|
Number of
shares of stock that have
not vested (#)
|
|
Market value
of shares of stock that have not vested ($)(1) |
||||||
|
Angelina M. Galiteva (2)(3)
|
|
12,500
|
|
|
12,500
|
|
|
2.60
|
|
|
2/14/2021
|
|
|
25,000
|
|
|
112,500
|
|
|
John N. Hatsopoulos
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
George N. Hatsopoulos
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
Ahmed F. Ghoniem (4)(5)
|
|
12,500
|
|
|
12,500
|
|
|
2.60
|
|
|
2/14/2021
|
|
|
25,000
|
|
|
112,500
|
|
|
Charles T. Maxwell (6)(7)
|
|
12,500
|
|
|
12,500
|
|
|
2.60
|
|
|
2/14/2021
|
|
|
25,000
|
|
|
112,500
|
|
|
Joseph E. Aoun (8)
|
|
—
|
|
|
25,000
|
|
|
4.50
|
|
|
12/31/2023
|
|
|
—
|
|
|
—
|
|
|
(1)
|
Market value of shares of Common Stock that have not vested is computed by the Company’s most recent private placement of Common Stock on January 17, 2014, which was $4.50 per share.
|
|
(2)
|
Includes 25,000 shares of restricted Common Stock at a purchase price of $.004 per share granted on December 13, 2006, with 100% of the shares vesting one year after the Company’s initial public offering.
|
|
(3)
|
Includes stock option award granted on February 15, 2011, with 25% of the shares vesting on February 15, 2012, and then an additional 25% of the shares vesting on each of the subsequent three anniversaries, provided that Ms. Galiteva serves as a director or consultant to the Company.
|
|
(4)
|
Includes stock option award granted on February 15, 2011, with 25% of the shares vesting on February 15, 2012, and then an additional 25% of the shares vesting on each of the subsequent three anniversaries, provided that Mr. Ghoniem serves as a director or consultant to the Company.
|
|
(5)
|
Includes 25,000 shares of restricted Common Stock at a purchase price of $.004 per share granted on October 1, 2008, with 100% of the shares vesting 180 days after the Company’s initial public offering.
|
|
(6)
|
Includes stock option award granted on February 15, 2011, with 25% of the shares vesting on February 15, 2012, and then an additional 25% of the shares vesting on each of the subsequent three anniversaries, provided that Mr. Maxwell serves as a director or consultant to the Company.
|
|
(7)
|
Includes 25,000 shares of restricted Common Stock at a purchase price of $.004 per share granted on October 1, 2008, with 100% of the shares vesting 180 days after the Company’s initial public offering.
|
|
(8)
|
Includes stock option award granted on December 31, 2013, with 25% of the shares vesting on December 31, 2014, and then an additional 25% of the shares vesting on each of the subsequent three anniversaries, provided that Dr. Aoun serves as a director or consultant to the Company.
|
|
•
|
each of our named executive officers;
|
|
•
|
all of our directors and executive officers as a group; and
|
|
•
|
each person, or group of affiliated persons, who is known to us to beneficially own more than 5% of our outstanding shares of Common Stock.
|
|
Name and address of beneficial owner
|
|
Amount and Nature of Beneficial Ownership
|
|
Percent of Class
|
||
|
5% Stockholders:
|
|
|
|
|
||
|
John N. Hatsopoulos (1)
|
|
3,718,939
|
|
|
24.5
|
%
|
|
George N. Hatsopoulos (2)
|
|
3,554,651
|
|
|
23.5
|
%
|
|
Michaelson Capital Special Finance Fund LP (3)
|
|
1,000,001
|
|
|
6.4
|
%
|
|
RBC Cees Nominees Limited (4)
|
|
904,105
|
|
|
6.0
|
%
|
|
Joseph J. Ritchie (5)
|
|
896,613
|
|
|
5.9
|
%
|
|
|
|
|
|
|
||
|
Directors and Officers:
|
|
|
|
|
||
|
John N. Hatsopoulos (1)
|
|
3,718,939
|
|
|
24.5
|
%
|
|
George N. Hatsopoulos (2)
|
|
3,554,651
|
|
|
23.5
|
%
|
|
Robert A. Panora (6)
|
|
225,850
|
|
|
1.5
|
%
|
|
Bonnie J. Brown (7)
|
|
106,250
|
|
|
0.7
|
%
|
|
Charles T. Maxwell (8)
|
|
87,500
|
|
|
0.6
|
%
|
|
Angelina M. Galiteva (9)
|
|
62,500
|
|
|
0.4
|
%
|
|
Ahmed F. Ghoniem (10)
|
|
37,500
|
|
|
0.2
|
%
|
|
Joseph E. Aoun
|
|
—
|
|
|
—
|
%
|
|
|
|
|
|
|
||
|
All executive officers and directors as a group (8 persons)
|
|
7,793,190
|
|
|
51.4
|
%
|
|
(1)
|
Includes:(a) 2,135,210 shares of Common Stock held by J&P Enterprises LLC for the benefit of: (1) John N. Hatsopoulos and (2) Patricia L. Hatsopoulos. John N. Hatsopoulos is the Executive Member of J&P Enterprises LLC and has voting and investment power; (b) 593,770 shares of Common Stock held by John N. Hatsopoulos and his wife, Patricia L. Hatsopoulos, as joint tenants with rights of survivorship, each of whom share voting and investment power; and (c) 989,859 shares of Common Stock held by The John N. Hatsopoulos Family Trust 2007 for the benefit of: (1) Patricia L. Hatsopoulos, (2) Alexander J. Hatsopoulos, and (3) Nia Marie Hatsopoulos, for which Dr. George N.
|
|
(2)
|
Includes: (a) 1,304,651 shares of Common Stock, directly held by Dr. George N. Hatsopoulos; (b) 2,250,000 shares of Common Stock held by The Hatsopoulos Family 2012 Trust.This amount does not include (a) 234,049 shares held in the 1994 Hatsopoulos Family Trust for the benefit of Marina Hatsopoulos Bornhorst, for which Ms. Daphne Hatsopoulos and Mr. Gordon Erhlich are the trustees. The trusts are for the benefit of Dr. Hatsopoulos's adult children. Dr. Hatsopoulos disclaims beneficial ownership of the shares held by this trust.
|
|
(3)
|
Includes: (a) 444,445 shares of Common Stock purchased December 23, 2013; and (b) 555,556 shares of Common Stock issuable upon conversion of $3,000,000 principal amount of 4% convertible debentures.
|
|
(4)
|
Includes 904,105 shares of Common Stock purchased in August 2010 and November 2011 held by RBC cees Nominees Ltd. The address of RBC cees Nominees Ltd. is 19-21 Broad Street, St. Hellier, Jersey JE1 3PB, Channel Islands.
|
|
(5)
|
Includes 896,613 shares of Common Stock, directly held by Mr. Ritchie. The address of Mr. Ritchie is 2100 Enterprise Avenue, Geneva, IL 60134.
|
|
(6)
|
Includes: (a) 163,350 shares of Common Stock, directly held by Mr. Panora, and (b) options to purchase 62,500 shares of Common Stock exercisable within 60 days of the date of
March 31, 2014
.
|
|
(7)
|
Includes: (a) 12,500 shares of Common Stock, directly held by Ms. Brown, and (b) options to purchase 93,750 shares of Common Stock exercisable within 60 days of the date of
March 31, 2014
.
|
|
(8)
|
Includes: (a) 75,000 shares of Common Stock, directly held by Mr. Maxwell, and (b) options to purchase 12,500 shares of Common Stock exercisable within 60 days of the date of
March 31, 2014
.
|
|
(9)
|
Includes: (a) 50,000 shares of Common Stock, directly held by Ms. Galiteva and (b) options to purchase 12,500 shares of Common Stock exercisable within 60 days of the date of
March 31, 2014
.
|
|
(10)
|
Includes: (a) 25,000 shares of Common Stock, directly held by Mr. Ghoniem, and (b) options to purchase 12,500 shares of Common Stock exercisable within 60 days of the date of
March 31, 2014
.
|
|
|
|
Number of securities to be issued upon exercise of outstanding options, warrants and rights
|
|
Weighted-average exercise price of outstanding options, warrants and rights
|
|
Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in second column)
|
||||
|
Equity compensation plans approved by security holders
|
|
1,148,000
|
|
|
$
|
2.13
|
|
|
540,732
|
|
|
Equity compensation plans not approved by security holders
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
Total
|
|
1,148,000
|
|
|
$
|
2.13
|
|
|
540,732
|
|
|
•
|
None of our executive officers receives any performance-based compensation or incentive payments.
|
|
•
|
A portion of the compensation package for our sales-based employees consists of commissions for units sold and installed, which package is designed to link an appropriate portion of compensation to long-term performance, while providing a balanced compensation model overall.
|
|
•
|
The Compensation Committee oversees our compensation policies and practices and is responsible for reviewing and approving executive compensation, annual incentive compensation plans applicable to sales employees and other compensation plans.
|
|
•
|
John N. Hatsopoulos, the Company’s Chief Executive Officer who is also: (a) the Chief Executive Officer and a director of American DG Energy and holds
10.7%
of the company’s common stock; (b) the Chairman of EuroSite Power; (c) a director of Ilios and holds
7.2%
of the company’s common stock; and (d) the Chairman of GlenRose Instruments and holds
15.7%
of the company’s common stock.
|
|
•
|
Dr. George N. Hatsopoulos, who is John N. Hatsopoulos’ brother, and is also: (a) a director of American DG Energy and holds
13.6%
of the company’s common stock; (b) an investor in Ilios and holds
3.1%
of the company’s common stock; (c) an investor of GlenRose Instruments and holds
15.7%
of the company’s common stock; (d) an investor of Pharos and may be deemed to hold
24.4%
of the company’s common stock; and (e) a director and an investor of Levitronix and may be deemed to hold
21.4%
of the company’s common stock.
|
|
•
|
Barry J. Sanders, who is: (a) the President and Chief Operating Officer of American DG Energy, (b) the Chief Executive Officer and a director of EuroSite Power and (c) the Chairman of Ilios.
|
|
•
|
Anthony S. Loumidis, the Company’s former Vice President and Treasurer who is: (a) the former Chief Financial Officer Secretary and Treasurer of American DG Energy, (b) the former Chief Financial Officer Secretary and Treasurer of EuroSite Power, (c) the former Chief Financial Officer Secretary and Treasurer of GlenRose Instruments and (d) the former Treasurer of Ilios.
|
|
(a)
|
a director who is, or during the past three years was, employed by the company, other than prior employment as an interim executive officer (provided the interim employment did not last longer than one year);
|
|
(b)
|
a director who accepted or has an immediate family member who accepted any compensation from the company in excess of $120,000 during any period of twelve consecutive months within the three years preceding the determination of independence, other than the following:
|
|
(i)
|
compensation for board or board committee service;
|
|
(ii)
|
compensation paid to an immediate family member who is an employee (other than an executive officer) of the company;
|
|
(iii)
|
compensation received for former service as an interim executive officer (provided the interim employment did not last longer than one year); or
|
|
(iv)
|
benefits under a tax-qualified retirement plan, or non-discretionary compensation;
|
|
(c)
|
a director who is an immediate family member of an individual who is, or at any time during the past three years was, employed by the company as an executive officer;
|
|
(d)
|
a director who is, or has an immediate family member who is, a partner in, or a controlling shareholder or an executive officer of, any organization to which the company made, or from which the company received, payments (other than those arising solely from investments in the company's securities or payments under non-discretionary charitable contribution matching programs) that exceed 5% of the organization's consolidated gross revenues for that year, or $200,000, whichever is more, in any of the most recent three fiscal years;
|
|
(e)
|
a director who is, or has an immediate family member who is, employed as an executive officer of another entity where at any time during the most recent three fiscal years any of the issuer's executive officers serve on the compensation committee of such other entity; or
|
|
(f)
|
a director who is, or has an immediate family member who is, a current partner of the company's outside auditor, or was a partner or employee of the company's outside auditor who worked on the company's audit at any time during any of the past three years.
|
|
|
|
December 31, 2013
|
|
December 31, 2012
|
||||
|
Audit fees
|
|
$
|
137,000
|
|
|
$
|
121,000
|
|
|
Audit-related fees (1)
|
|
101,110
|
|
|
69,500
|
|
||
|
Tax fees
|
|
—
|
|
|
—
|
|
||
|
All other fees
|
|
—
|
|
|
—
|
|
||
|
Total
|
|
$
|
238,110
|
|
|
$
|
190,500
|
|
|
Number
|
Description
|
|
3.1
|
Certificate of Incorporation, as amended and restated February 11, 2013 (incorporated by reference to Exhibit 3.2 to the Company's Form S-1, as amended, originally filed with the SEC on December 22, 2011).
|
|
3.2
|
Bylaws as amended and restated February 14, 2013 (incorporated by reference to Exhibit 3.4 to the Company's Form S-1, as amended, originally filed with the SEC on December 22, 2011).
|
|
4.1
|
Specimen Common Stock Certificate of Tecogen Inc (incorporated by reference to Exhibit 4.1 to the Company's Form S-1, as amended, originally filed with the SEC on December 22, 2011).
|
|
4.2
|
Form of Restricted Stock Purchase Agreement (incorporated by reference to Exhibit 4.2 to the Company's Form S-1, as amended, originally filed with the SEC on December 22, 2011).
|
|
4.3*
|
Form of Stock Option Agreement (incorporated by reference to Exhibit 4.3 to the Company's Form S-1, as amended, originally filed with the SEC on December 22, 2011).
|
|
4.4
|
Indenture and Form of 6% Convertible Debenture Due 2004, dated September 24, 2001 (incorporated by reference to Exhibit 4.4 to the Company's Form S-1, as amended, originally filed with the SEC on December 22, 2011).
|
|
10.1*
|
Tecogen Inc. 2006 Stock Incentive Plan, as amended on November 10, 2011 (incorporated by reference to Exhibit 10.5 to the Company's Form S-1, as amended, originally filed with the SEC on December 22, 2011).
|
|
10.2
|
Form of Tecogen Inc. Subscription Agreement for private placement of Common Stock (incorporated by reference to Exhibit 10.5 to the Company's Form S-1, as amended, originally filed with the SEC on December 22, 2011).
|
|
10.3+
|
Facilities, Support Services and Business Agreement between American DG Energy Inc. and Tecogen Inc., dated January 1, 2006 (incorporated by reference to Exhibit 10.6 to the Company's Form S-1, as amended, originally filed with the SEC on December 22, 2011).
|
|
10.4
|
First Amendment to the Facilities, Support Services, and Business Agreement between American DG Energy Inc. and Tecogen Inc., dated as of July 1, 2013 (incorporated by reference to Exhibit 10.1 to the Company’s Form 8-K, originally filed with the SEC on July 3, 2013).
|
|
10.5
|
Second Amendment to the Facilities, Support Services, and Business Agreement between American DG Energy Inc. and Tecogen Inc., dated November 12, 2013 (incorporated by reference to Exhibit 10.1 to the Company’s Form 10-Q for the quarter ended September 30, 2013, originally filed with the SEC on November 14, 2013).
|
|
10.6+
|
General Motors LLC, Customer Care and Aftersales Agreement, dated November 15, 2011 (incorporated by reference to Exhibit 10.7 to the Company's Form S-1, as amended, originally filed with the SEC on December 22, 2011).
|
|
10.7
|
Lease Agreement between Atlantic-Waltham Investment II, LLC, and Tecogen Inc., dated May 14, 2008 (incorporated by reference to Exhibit 10.8 to the Company's Form S-1, as amended, originally filed with the SEC on December 22, 2011).
|
|
10.8*
|
Form of Demand Note Agreement with John Hatsopoulos (incorporated by reference to Exhibit 10.9 to the Company's Form S-1, as amended, originally filed with the SEC on December 22, 2011).
|
|
10.9
|
Form of Sales Representative Agreement (incorporated by reference to Exhibit 10.10 to the Company's Form S-1, as amended, originally filed with the SEC on December 22, 2011).
|
|
10.10+
|
Asset Purchase Agreement with Danotek (assignment for the benefit of creditors), LLC, dated January 8, 2013 (incorporated by reference to Exhibit 10.11 to the Company's Form S-1, as amended, originally filed with the SEC on December 22, 2011).
|
|
10.11+
|
Exclusive License Agreement between Tecogen Inc. and the Wisconsin Alumni Research Foundation, dated February 5, 2007 (incorporated by reference to Exhibit 10.12 to the Company's Form S-1, as amended, originally filed with the SEC on December 22, 2011).
|
|
10.12+
|
Grant Award Number PIR-08-022, dated July 2, 2009 (incorporated by reference to Exhibit 10.13 to the Company's Form S-1, as amended, originally filed with the SEC on December 22, 2011).
|
|
10.13+
|
Sales Representative Agreement between American DG Energy Inc. and Ilios Dynamics, dated October 20, 2009 (incorporated by reference to Exhibit 10.14 to the Company's Form S-1, as amended, originally filed with the SEC on December 22, 2011).
|
|
10.14
|
First Amendment to the Sales Representative Agreement between American DG Energy Inc. and Ilios Inc., dated November 12, 2013 (incorporated by reference to Exhibit 10.2 to the Company’s Form 10-Q for the quarter ended September 30, 2013, originally filed with the SEC on November 14, 2013).
|
|
10.15
|
Revolving Line of Credit Agreement between Tecogen Inc. and John N. Hatsopoulos, dated March 25, 2013 (incorporated by reference to Exhibit 10.1 to the Company's Form 8-K, originally filed with the SEC on May 2, 2013).
|
|
10.16
|
First Amendment to the Revolving Line of Credit Agreement between Tecogen Inc. and John N. Hatsopoulos, dated August 13, 2013 (incorporated by reference to Exhibit 10.2 to the Company’s Form 10-Q for the quarter ended June 30, 2013, originally filed with the SEC on August 14, 2013).
|
|
10.17
|
Form of Common Stock Purchase Agreement (incorporated by reference to Exhibit 10.1 to the Company’s Form 8-K, originally filed with the SEC on October 21, 2013).
|
|
10.18
|
Form of Common Stock Purchase Agreement (incorporated by reference to Exhibit 10.1 to the Company’s Forms 8-K, originally filed with the SEC on November 8, 2013 and November 13, 2013).
|
|
10.19
|
Demand Promissory Note between John N. Hatsopoulos and Tecogen Inc., dated October 3, 2013 (incorporated by reference to Exhibit 10.3 to the Company’s Form 10-Q for the quarter ended September 30, 2013, originally filed with the SEC on November 14, 2013).
|
|
10.20
|
Senior Convertible Promissory Note issued to Michaelson Capital Special Finance Fund LP, dated December 23, 2013 (incorporated by reference to Exhibit 10.1 to the Company’s Form 8-K, originally filed with the SEC on December 30, 2013).
|
|
10.21#
|
Collective Bargaining Agreement, dated February 25, 2014, between Tecogen, Inc. and International Union of Operating Engineers, Local 68, 68A, 68B.
|
|
10.22#
|
Revolving Line of Credit Agreement between Tecogen Inc. and John N. Hatsopoulos, dated March 26, 2014
|
|
14.1
|
Code of Business Conduct and Ethics (incorporated by reference to Exhibit 14.1 to the Company's Form S-1, as amended, originally filed with the SEC on December 22, 2011).
|
|
21.1
|
List of subsidiaries (incorporated by reference to Exhibit 21.1 to the Company's Form S-1, as amended, originally filed with the SEC on December 22, 2011).
|
|
31.1#
|
Rule 13a-14(a) Certification of Chief Executive Officer.
|
|
31.2#
|
Rule 13a-14(a) Certification of Chief Financial Officer.
|
|
32.1#
|
Section 1350 Certifications of Chief Executive Officer and Chief Financial Officer (Furnished herewith).
|
|
101.1
|
The following materials from the Company's Annual Report on Form 10-K for the year ended
December 31, 2013
formatted in XBRL (eXtensible Business Reporting Language): (i) the Consolidated Balance Sheets, (ii) the Consolidated Statements of Operations, (iii) the Consolidated Statements of Stockholders' Equity, (iv) the Consolidated Statements of Cash Flows, and (v) related notes to these financial statements, tagged as blocks of text and in detail (Furnished herewith).
|
|
#
|
Filed herewith.
|
|
*
|
Management contract or compensatory plan or arrangement.
|
|
+
|
Previously filed with the Securities and Exchange Commission as an Exhibit to the Company's Form S-1, as amended. Confidential Treatment has been granted for portions of this document. The confidential portions were omitted and filed separately, on a confidential basis, with the Securities and Exchange Commission.
|
|
|
TECOGEN INC.
|
|
|
|
(Registrant)
|
|
|
|
|
|
|
|
By:
|
/s/ John N. Hatsopoulos
|
|
|
Chief Executive Officer
|
|
|
|
(Principal Executive Officer)
|
|
|
|
|
|
|
|
By:
|
/s/ Bonnie J. Brown
|
|
|
Chief Financial Officer, Treasurer and Secretary
|
|
|
|
(Principal Financial and Accounting Officer)
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
|
/s/ Angelina M. Galiteva
|
|
Chairman of the Board
|
|
March 31, 2014
|
|
Angelina M. Galiteva
|
|
|
|
|
|
|
|
|
|
|
|
/s/ John N. Hatsopoulos
|
|
Director and Chief Executive Officer
|
|
March 31, 2014
|
|
John N. Hatsopoulos
|
|
(Principal Executive Officer)
|
|
|
|
|
|
|
|
|
|
/s/ Bonnie J. Brown
|
|
Chief Financial Officer, Treasurer and Secretary
|
|
March 31, 2014
|
|
Bonnie J. Brown
|
|
Principal Financial and Accounting Officer)
|
|
|
|
|
|
|
|
|
|
/s/ George N. Hatsopoulos
|
|
Director
|
|
March 31, 2014
|
|
George N. Hatsopoulos
|
|
|
|
|
|
|
|
|
|
|
|
/s/ Charles T. Maxwell
|
|
Director
|
|
March 31, 2014
|
|
Charles T. Maxwell
|
|
|
|
|
|
|
|
|
|
|
|
/s/ Ahmed F. Ghoniem
|
|
Director
|
|
March 31, 2014
|
|
Ahmed F. Ghoniem
|
|
|
|
|
|
|
|
|
|
|
|
/s/ Joseph E. Aoun
|
|
Director
|
|
March 31, 2014
|
|
Joseph E. Aoun
|
|
|
|
|
|
|
2013
|
|
2012
|
||||
|
ASSETS
|
|
|
|
|
|
||
|
Current assets:
|
|
|
|
|
|
||
|
Cash and cash equivalents
|
$
|
7,713,899
|
|
|
$
|
1,572,785
|
|
|
Short-term investments, restricted
|
—
|
|
|
181,859
|
|
||
|
Accounts receivable, net
|
3,740,885
|
|
|
2,700,243
|
|
||
|
Unbilled revenue
|
646,398
|
|
|
—
|
|
||
|
Inventory, net
|
3,343,793
|
|
|
3,356,622
|
|
||
|
Due from related party
|
—
|
|
|
55,837
|
|
||
|
Deferred financing costs
|
140,433
|
|
|
—
|
|
||
|
Prepaid and other current assets
|
340,013
|
|
|
402,846
|
|
||
|
Total current assets
|
15,925,421
|
|
|
8,270,192
|
|
||
|
|
|
|
|
||||
|
Property, plant and equipment, net
|
638,026
|
|
|
435,612
|
|
||
|
Intangible assets, net
|
953,327
|
|
|
372,020
|
|
||
|
Goodwill
|
40,870
|
|
|
—
|
|
||
|
Other assets
|
72,425
|
|
|
39,425
|
|
||
|
TOTAL ASSETS
|
$
|
17,630,069
|
|
|
$
|
9,117,249
|
|
|
|
|
|
|
||||
|
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
|
|
|
|
|
||
|
Current liabilities:
|
|
|
|
|
|
||
|
Demand notes payable and line of credit, related party
|
$
|
2,950,000
|
|
|
$
|
1,337,500
|
|
|
Senior convertible promissory note, related party
|
3,000,000
|
|
|
—
|
|
||
|
Current portion of convertible debentures, related party
|
—
|
|
|
90,967
|
|
||
|
Accounts payable
|
2,338,046
|
|
|
1,151,010
|
|
||
|
Accrued expenses
|
1,139,554
|
|
|
807,922
|
|
||
|
Deferred revenue
|
613,915
|
|
|
677,919
|
|
||
|
Due to related party
|
119,667
|
|
|
—
|
|
||
|
Interest payable, related party
|
198,450
|
|
|
126,170
|
|
||
|
Total current liabilities
|
10,359,632
|
|
|
4,191,488
|
|
||
|
|
|
|
|
||||
|
Long-term liabilities:
|
|
|
|
|
|
||
|
Deferred revenue, net of current portion
|
204,544
|
|
|
142,726
|
|
||
|
Total liabilities
|
10,564,176
|
|
|
4,334,214
|
|
||
|
|
|
|
|
||||
|
Commitments and contingencies (Note 8)
|
|
|
|
|
|
||
|
|
|
|
|
||||
|
Stockholders’ equity:
|
|
|
|
|
|
||
|
Tecogen Inc. stockholders’ equity:
|
|
|
|
|
|
||
|
Common stock, $0.001 par value; 100,000,000 shares authorized; 15,155,200 and 13,611,974 issued and outstanding at December 31, 2013 and 2012, respectively
|
15,155
|
|
|
13,612
|
|
||
|
Additional paid-in capital
|
22,463,996
|
|
|
16,360,821
|
|
||
|
Accumulated deficit
|
(15,209,212
|
)
|
|
(11,759,723
|
)
|
||
|
Total Tecogen Inc. stockholders’ equity
|
7,269,939
|
|
|
4,614,710
|
|
||
|
Noncontrolling interest
|
(204,046
|
)
|
|
168,325
|
|
||
|
Total stockholders’ equity
|
7,065,893
|
|
|
4,783,035
|
|
||
|
|
|
|
|
||||
|
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY
|
$
|
17,630,069
|
|
|
$
|
9,117,249
|
|
|
|
2013
|
|
2012
|
||||
|
Revenues
|
|
|
|
|
|
||
|
Products
|
$
|
6,346,050
|
|
|
$
|
7,453,222
|
|
|
Services
|
9,503,819
|
|
|
7,800,750
|
|
||
|
|
15,849,869
|
|
|
15,253,972
|
|
||
|
Cost of sales
|
|
|
|
|
|
||
|
Products
|
4,709,767
|
|
|
5,290,535
|
|
||
|
Services
|
6,109,974
|
|
|
4,098,363
|
|
||
|
|
10,819,741
|
|
|
9,388,898
|
|
||
|
|
|
|
|
||||
|
Gross profit
|
5,030,128
|
|
|
5,865,074
|
|
||
|
|
|
|
|
||||
|
Operating expenses
|
|
|
|
|
|
||
|
General and administrative
|
7,018,133
|
|
|
6,643,120
|
|
||
|
Selling
|
1,423,587
|
|
|
1,225,580
|
|
||
|
Aborted public offering costs
|
258,512
|
|
|
—
|
|
||
|
|
8,700,232
|
|
|
7,868,700
|
|
||
|
|
|
|
|
||||
|
Loss from operations
|
(3,670,104
|
)
|
|
(2,003,626
|
)
|
||
|
|
|
|
|
||||
|
Other income (expense)
|
|
|
|
|
|
||
|
Interest and other income
|
3,958
|
|
|
48,397
|
|
||
|
Interest expense
|
(141,065
|
)
|
|
(71,208
|
)
|
||
|
|
(137,107
|
)
|
|
(22,811
|
)
|
||
|
|
|
|
|
||||
|
Loss before income taxes
|
(3,807,211
|
)
|
|
(2,026,437
|
)
|
||
|
Consolidated net loss
|
(3,807,211
|
)
|
|
(2,026,437
|
)
|
||
|
|
|
|
|
||||
|
Less: Loss attributable to the noncontrolling interest
|
357,722
|
|
|
389,480
|
|
||
|
Net loss attributable to Tecogen Inc.
|
$
|
(3,449,489
|
)
|
|
$
|
(1,636,957
|
)
|
|
|
|
|
|
||||
|
Net loss per share - basic and diluted
|
$
|
(0.26
|
)
|
|
$
|
(0.12
|
)
|
|
|
|
|
|
||||
|
Weighted average shares outstanding - basic and diluted
|
13,385,155
|
|
|
13,135,071
|
|
||
|
|
Tecogen Inc.
|
|
|
|
|
||||||||||||||||||||||
|
|
Common
Stock
0.001
Par Value
|
|
Additional
Paid-In
Capital
|
|
Common
Stock
Subscription
|
|
Shareholder
Receivable
|
|
Accumulated
Deficit
|
|
Noncontrolling
Interest
|
|
Total
|
||||||||||||||
|
Balance at December 31, 2011
|
$
|
13,498
|
|
|
$
|
15,527,271
|
|
|
$
|
—
|
|
|
$
|
(345,000
|
)
|
|
$
|
(10,122,766
|
)
|
|
$
|
150,161
|
|
|
$
|
5,223,164
|
|
|
Sale of subsidiary common stock
|
—
|
|
|
289,606
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
210,394
|
|
|
500,000
|
|
|||||||
|
Purchase of subsidiary common stock
|
—
|
|
|
(174,958
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
174,958
|
|
|
—
|
|
|||||||
|
Sale of common stock
|
213
|
|
|
679,787
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
680,000
|
|
|||||||
|
Conversion of related party convertible notes to common stock
|
83
|
|
|
99,917
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
100,000
|
|
|||||||
|
Conversion of accrued interest on related party convertible notes to common stock
|
2
|
|
|
6,098
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
6,100
|
|
|||||||
|
Settlement of shareholder receivable (Note 10)
|
(100
|
)
|
|
(239,900
|
)
|
|
—
|
|
|
345,000
|
|
|
—
|
|
|
—
|
|
|
105,000
|
|
|||||||
|
Purchase of restricted stock
|
(84
|
)
|
|
(253
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(337
|
)
|
|||||||
|
Stock based compensation expense
|
—
|
|
|
173,253
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
22,292
|
|
|
195,545
|
|
|||||||
|
Net loss
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(1,636,957
|
)
|
|
(389,480
|
)
|
|
(2,026,437
|
)
|
|||||||
|
Balance at December 31, 2012
|
13,612
|
|
|
16,360,821
|
|
|
—
|
|
|
—
|
|
|
(11,759,723
|
)
|
|
168,325
|
|
|
4,783,035
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
|
Sale of common stock
|
1,477
|
|
|
5,965,328
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
5,966,805
|
|
|||||||
|
Conversion of related party convertible notes to common stock
|
76
|
|
|
90,891
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
90,967
|
|
|||||||
|
Conversion of accrued interest on related party convertible notes to common stock
|
3
|
|
|
11,277
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
11,280
|
|
|||||||
|
Exercise of stock options
|
25
|
|
|
2,975
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
3,000
|
|
|||||||
|
Forfeiture and repurchase of restricted stock grant
|
(38
|
)
|
|
(112
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(200
|
)
|
|
(350
|
)
|
|||||||
|
Stock based compensation expense (forfeiture)
|
—
|
|
|
32,816
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(14,449
|
)
|
|
18,367
|
|
|||||||
|
Net loss
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(3,449,489
|
)
|
|
(357,722
|
)
|
|
(3,807,211
|
)
|
|||||||
|
Balance at December 31, 2013
|
$
|
15,155
|
|
|
$
|
22,463,996
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
(15,209,212
|
)
|
|
$
|
(204,046
|
)
|
|
$
|
7,065,893
|
|
|
|
2013
|
|
2012
|
||||
|
CASH FLOWS FROM OPERATING ACTIVITIES:
|
|
|
|
|
|
||
|
Net loss
|
$
|
(3,807,211
|
)
|
|
$
|
(2,026,437
|
)
|
|
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
|
|
|
|
|
|
||
|
Depreciation and amortization
|
256,459
|
|
|
203,775
|
|
||
|
Provision for losses on accounts receivable
|
50,600
|
|
|
57,600
|
|
||
|
Provision (recovery) for inventory reserve
|
(32,000
|
)
|
|
(26,800
|
)
|
||
|
Stock-based compensation
|
18,367
|
|
|
195,545
|
|
||
|
Changes in operating assets and liabilities
|
|
|
|
|
|
||
|
(Increase) decrease in:
|
|
|
|
|
|
||
|
Short-term investments, restricted
|
(202
|
)
|
|
(4,776
|
)
|
||
|
Accounts receivable
|
(1,091,242
|
)
|
|
(1,358,611
|
)
|
||
|
Inventory
|
62,229
|
|
|
(760,836
|
)
|
||
|
Unbilled revenue
|
(646,398
|
)
|
|
—
|
|
||
|
Due from related party
|
55,837
|
|
|
243,902
|
|
||
|
Prepaid expenses and other current assets
|
62,833
|
|
|
(290,130
|
)
|
||
|
Other assets
|
(33,000
|
)
|
|
(4,000
|
)
|
||
|
Increase (decrease) in:
|
|
|
|
|
|
||
|
Accounts payable
|
1,187,036
|
|
|
338,796
|
|
||
|
Accrued expenses
|
331,632
|
|
|
80,459
|
|
||
|
Deferred revenue
|
(2,186
|
)
|
|
127,523
|
|
||
|
Interest payable, related party
|
83,560
|
|
|
71,208
|
|
||
|
Due to related party
|
119,667
|
|
|
—
|
|
||
|
Net cash used in operating activities
|
(3,384,019
|
)
|
|
(3,152,782
|
)
|
||
|
CASH FLOWS FROM INVESTING ACTIVITIES:
|
|
|
|
|
|
||
|
Purchases of property and equipment
|
(202,700
|
)
|
|
(219,711
|
)
|
||
|
Purchases of intangible assets
|
(397,950
|
)
|
|
(164,296
|
)
|
||
|
Cash paid for asset acquisition
|
(497,800
|
)
|
|
—
|
|
||
|
Maturities of short-term investments
|
182,061
|
|
|
506,345
|
|
||
|
Net cash provided by (used in) investing activities
|
(916,389
|
)
|
|
122,338
|
|
||
|
CASH FLOWS FROM FINANCING ACTIVITIES:
|
|
|
|
|
|
||
|
Payments made on demand notes payable, related party
|
(37,500
|
)
|
|
—
|
|
||
|
Proceeds from payments on receivable from shareholder
|
—
|
|
|
105,000
|
|
||
|
Proceeds from issuance of demand notes payable and line of credit, related party
|
1,650,000
|
|
|
300,000
|
|
||
|
Proceeds from sale of common stock, net of costs
|
5,966,805
|
|
|
680,000
|
|
||
|
Proceeds from exercise of stock options
|
3,000
|
|
|
—
|
|
||
|
Proceeds from issuance of senior convertible promissory note
|
3,000,000
|
|
|
—
|
|
||
|
Payments from debt issuance costs
|
(140,433
|
)
|
|
—
|
|
||
|
Purchase of restricted stock
|
(350
|
)
|
|
(337
|
)
|
||
|
Proceeds from sale of subsidiary common stock
|
—
|
|
|
500,000
|
|
||
|
Net cash provided by financing activities
|
10,441,522
|
|
|
1,584,663
|
|
||
|
Net increase (decrease) in cash and cash equivalents
|
6,141,114
|
|
|
(1,445,781
|
)
|
||
|
Cash and cash equivalents, beginning of the year
|
1,572,785
|
|
|
3,018,566
|
|
||
|
Cash and cash equivalents, end of the year
|
$
|
7,713,899
|
|
|
$
|
1,572,785
|
|
|
Supplemental disclosures of cash flows information:
|
|
|
|
|
|
||
|
Cash paid for interest
|
$
|
55,639
|
|
|
$
|
—
|
|
|
Non-cash investing and financing activities:
|
|
|
|
|
|
||
|
Conversion of accrued convertible debenture interest into common stock
|
$
|
11,280
|
|
|
$
|
6,100
|
|
|
Conversion of related party notes to common stock
|
$
|
90,967
|
|
|
$
|
100,000
|
|
|
Settlement of shareholder receivable
|
$
|
—
|
|
|
$
|
240,000
|
|
|
|
2013
|
|
2012
|
||||
|
Products:
|
|
|
|
|
|
||
|
Cogeneration
|
$
|
5,199,649
|
|
|
$
|
5,791,412
|
|
|
Chiller
|
1,146,401
|
|
|
1,661,810
|
|
||
|
Total Product Revenue
|
6,346,050
|
|
|
7,453,222
|
|
||
|
Services
|
|
|
|
||||
|
Service contracts
|
7,071,388
|
|
|
7,089,491
|
|
||
|
Installations
|
2,432,431
|
|
|
711,259
|
|
||
|
Total Service Revenue
|
9,503,819
|
|
|
7,800,750
|
|
||
|
|
$
|
15,849,869
|
|
|
$
|
15,253,972
|
|
|
|
2013
|
|
2012
|
||||
|
Loss available to stockholders
|
$
|
(3,449,489
|
)
|
|
$
|
(1,636,957
|
)
|
|
|
|
|
|
||||
|
Weighted average shares outstanding - Basic and diluted
|
13,385,155
|
|
|
13,135,071
|
|
||
|
Basic and diluted loss per share
|
$
|
(0.26
|
)
|
|
$
|
(0.12
|
)
|
|
|
|
|
|
||||
|
Anti-dilutive shares underlying stock options outstanding
|
1,148,000
|
|
|
1,096,500
|
|
||
|
Anti-dilutive convertible debentures
|
555,556
|
|
|
75,806
|
|
||
|
|
2013
|
|
2012
|
||||
|
Gross raw materials
|
$
|
3,539,732
|
|
|
$
|
3,574,620
|
|
|
Less - reserves
|
(300,000
|
)
|
|
(332,000
|
)
|
||
|
Net raw materials
|
3,239,732
|
|
|
3,242,620
|
|
||
|
Work-in-process
|
104,061
|
|
|
114,002
|
|
||
|
Finished goods
|
—
|
|
|
—
|
|
||
|
|
$
|
3,343,793
|
|
|
$
|
3,356,622
|
|
|
|
Product
Certifications
|
|
Patents
|
|
Developed Technology
|
|
Total
|
||||||||
|
Balance at December 31, 2013
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Intangible assets
|
$
|
406,706
|
|
|
$
|
441,609
|
|
|
240,000
|
|
|
$
|
1,088,315
|
|
|
|
Less - accumulated amortization
|
(83,405
|
)
|
|
(39,583
|
)
|
|
(12,000
|
)
|
|
(134,988
|
)
|
||||
|
|
$
|
323,301
|
|
|
$
|
402,026
|
|
|
$
|
228,000
|
|
|
$
|
953,327
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Balance at December 31, 2012
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Intangible assets
|
$
|
235,482
|
|
|
$
|
214,883
|
|
|
—
|
|
|
$
|
450,365
|
|
|
|
Less - accumulated amortization
|
(57,798
|
)
|
|
(20,547
|
)
|
|
—
|
|
|
(78,345
|
)
|
||||
|
|
$
|
177,684
|
|
|
$
|
194,336
|
|
|
$
|
—
|
|
|
$
|
372,020
|
|
|
2014
|
$
|
80,937
|
|
|
2015
|
119,758
|
|
|
|
2016
|
119,758
|
|
|
|
2017
|
119,758
|
|
|
|
2018
|
113,560
|
|
|
|
Thereafter
|
399,556
|
|
|
|
|
$
|
953,327
|
|
|
|
Estimated Useful
Life (in Years)
|
|
2013
|
|
2012
|
||||
|
Machinery and equipment
|
5 - 7 years
|
|
$
|
773,894
|
|
|
$
|
478,290
|
|
|
Furniture and fixtures
|
5 years
|
|
79,612
|
|
|
54,058
|
|
||
|
Computer software
|
3 - 5 years
|
|
67,215
|
|
|
56,935
|
|
||
|
Leasehold improvements
|
*
|
|
397,158
|
|
|
326,366
|
|
||
|
|
|
|
1,317,879
|
|
|
915,649
|
|
||
|
Less - accumulated depreciation and amortization
|
|
|
(679,853
|
)
|
|
(480,037
|
)
|
||
|
Net property, plant and equipment
|
|
|
$
|
638,026
|
|
|
$
|
435,612
|
|
|
2014
|
$
|
171,691
|
|
|
2015
|
130,287
|
|
|
|
2016
|
105,792
|
|
|
|
2017
|
79,616
|
|
|
|
2018
|
52,851
|
|
|
|
Thereafter
|
97,789
|
|
|
|
|
$
|
638,026
|
|
|
Years Ending December 31,
|
|
Amount
|
||
|
2014
|
|
$
|
579,495
|
|
|
2015
|
|
535,349
|
|
|
|
2016
|
|
485,040
|
|
|
|
2017
|
|
491,920
|
|
|
|
2018
|
|
499,122
|
|
|
|
2019 and thereafter
|
|
2,742,217
|
|
|
|
Total
|
|
$
|
5,333,143
|
|
|
Warranty reserve, December 31, 2011
|
$
|
57,000
|
|
|
Warranty provision for units sold
|
160,684
|
|
|
|
Costs of warranty incurred
|
(127,484
|
)
|
|
|
Warranty reserve, December 31, 2012
|
90,200
|
|
|
|
Warranty provision for units sold
|
179,841
|
|
|
|
Costs of warranty incurred
|
(175,041
|
)
|
|
|
Warranty reserve, December 31, 2013
|
$
|
95,000
|
|
|
Common Stock Options
|
Number of
Options
|
|
Exercise
Price Per
Share
|
|
Weighted
Average Exercise
Price
|
|
Weighted
Average Remaining
Life
|
|
Aggregate
Intrinsic
Value
|
||||||
|
Outstanding, December 31, 2011
|
1,095,250
|
|
|
$0.12-$2.80
|
|
|
$
|
1.92
|
|
|
5.53 years
|
|
$
|
1,387,150
|
|
|
Granted
|
17,500
|
|
|
3.20
|
|
|
3.20
|
|
|
|
|
|
|
||
|
Exercised
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
||
|
Canceled and forfeited
|
(15,938
|
)
|
|
1.20 - 2.60
|
|
|
1.28
|
|
|
|
|
|
|
||
|
Expired
|
(313
|
)
|
|
2.60
|
|
|
2.60
|
|
|
|
|
|
|
||
|
Outstanding, December 31, 2012
|
1,096,500
|
|
|
$0.12-$3.20
|
|
|
$
|
1.96
|
|
|
4.66 years
|
|
$
|
1,356,400
|
|
|
Exercisable, December 31, 2012
|
662,563
|
|
|
|
|
|
$
|
1.56
|
|
|
|
|
$
|
1,096,225
|
|
|
Vested and expected to vest, December 31, 2012
|
1,096,500
|
|
|
|
|
|
$
|
1.96
|
|
|
|
|
$
|
1,356,400
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Outstanding, December 31, 2012
|
1,096,500
|
|
|
$0.12-$3.20
|
|
|
$
|
1.96
|
|
|
4.66 years
|
|
$
|
1,356,400
|
|
|
Granted
|
76,500
|
|
|
3.20-4.50
|
|
|
3.86
|
|
|
|
|
|
|
||
|
Exercised
|
(25,000
|
)
|
|
0.12
|
|
|
0.12
|
|
|
|
|
|
|
||
|
Canceled and forfeited
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
||
|
Expired
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
||
|
Outstanding, December 31, 2013
|
1,148,000
|
|
|
$1.20-$4.50
|
|
|
$
|
2.13
|
|
|
5.80 years
|
|
$
|
2,721,100
|
|
|
Exercisable, December 31, 2013
|
799,500
|
|
|
|
|
|
$
|
1.79
|
|
|
|
|
$
|
2,166,550
|
|
|
Vested and expected to vest, December 31, 2013
|
1,148,000
|
|
|
|
|
|
$
|
2.13
|
|
|
|
|
$
|
2,721,100
|
|
|
|
2013
|
|
2012
|
|
Stock option awards:
|
|
|
|
|
Expected life
|
5.63 years
|
|
6.25 years
|
|
Risk-free interest rate
|
1.34%
|
|
0.70%
|
|
Expected volatility
|
26.5%-36.1%
|
|
35.9%-36.0%
|
|
|
Number of
Restricted
Stock
|
|
Weighted
Average
Grant Date
Fair Value
|
|||
|
Unvested, December 31, 2011
|
483,317
|
|
|
$
|
1.44
|
|
|
Granted
|
—
|
|
|
—
|
|
|
|
Vested
|
—
|
|
|
—
|
|
|
|
Forfeited
|
(84,247
|
)
|
|
1.36
|
|
|
|
Unvested, December 31, 2012
|
399,070
|
|
|
$
|
1.44
|
|
|
|
|
|
|
|||
|
Granted
|
—
|
|
|
—
|
|
|
|
Vested
|
—
|
|
|
—
|
|
|
|
Forfeited
|
(37,500
|
)
|
|
2.60
|
|
|
|
Unvested, December 31, 2013
|
361,570
|
|
|
$
|
1.31
|
|
|
Common Stock Options
|
Number of
Options
|
|
Exercise
Price Per
Share
|
|
Weighted
Average Exercise
Price
|
|
Weighted
Average Remaining
Life
|
|
Aggregate
Intrinsic
Value
|
||||||
|
Outstanding, December 31, 2011
|
525,000
|
|
|
$0.10-$0.50
|
|
|
$
|
0.27
|
|
|
8.23 years
|
|
$
|
120,000
|
|
|
Granted
|
50,000
|
|
|
0.50
|
|
|
0.50
|
|
|
|
|
|
|
||
|
Exercised
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
||
|
Canceled and forfeited
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
||
|
Expired
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
||
|
Outstanding, December 31, 2012
|
575,000
|
|
|
$0.10-$0.50
|
|
|
$
|
0.29
|
|
|
7.44 years
|
|
$
|
120,000
|
|
|
Exercisable, December 31, 2012
|
—
|
|
|
|
|
|
$
|
—
|
|
|
|
|
$
|
—
|
|
|
Vested and expected to vest, December 31, 2012
|
575,000
|
|
|
|
|
|
$
|
0.29
|
|
|
|
|
$
|
120,000
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Outstanding, December 31, 2012
|
575,000
|
|
|
$0.10-$0.50
|
|
|
$
|
0.29
|
|
|
7.44 years
|
|
$
|
120,000
|
|
|
Granted
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
||
|
Exercised
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
||
|
Canceled and forfeited
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
||
|
Expired
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
|
|
||
|
Outstanding, December 31, 2013
|
575,000
|
|
|
$0.10-$0.50
|
|
|
$
|
0.29
|
|
|
6.44 years
|
|
$
|
120,000
|
|
|
Exercisable, December 31, 2013
|
—
|
|
|
|
|
|
$
|
0.50
|
|
|
|
|
$
|
—
|
|
|
Vested and expected to vest, December 31, 2013
|
575,000
|
|
|
|
|
|
$
|
0.29
|
|
|
|
|
$
|
120,000
|
|
|
|
|
2012
|
|
Stock option awards:
|
|
|
|
Expected life
|
|
6.25 years
|
|
Risk-free interest rate
|
|
2.03%
|
|
Expected volatility
|
|
36.1%
|
|
|
Number of
Restricted
Stock
|
|
Weighted
Average
Grant Date
Fair Value
|
|||
|
Unvested, December 31, 2011
|
560,000
|
|
|
$
|
0.24
|
|
|
Granted
|
—
|
|
|
—
|
|
|
|
Vested
|
—
|
|
|
—
|
|
|
|
Forfeited
|
(50,000
|
)
|
|
0.10
|
|
|
|
Unvested, December 31, 2012
|
510,000
|
|
|
$
|
0.24
|
|
|
|
|
|
|
|||
|
Granted
|
—
|
|
|
—
|
|
|
|
Vested
|
—
|
|
|
—
|
|
|
|
Forfeited
|
(200,000
|
)
|
|
0.50
|
|
|
|
Unvested, December 31, 2013
|
310,000
|
|
|
$
|
0.10
|
|
|
|
2013
|
|
2012
|
||||
|
Net loss attributable to Tecogen Inc.
|
$
|
(3,449,489
|
)
|
|
$
|
(1,636,957
|
)
|
|
Transfers (to) from the noncontrolling interest
|
|
|
|
|
|
||
|
Decrease in Tecogen's paid-in capital for purchase of 1,000,000 Ilios common shares
|
—
|
|
|
(174,958
|
)
|
||
|
Increase in Tecogen's paid-in capital upon the sale of 1,000,000 Ilios common shares
|
—
|
|
|
289,606
|
|
||
|
|
|
|
|
||||
|
Net transfers to noncontrolling interest
|
—
|
|
|
114,648
|
|
||
|
Change from net loss attributable to Tecogen Inc. and transfers to noncontrolling interest
|
$
|
(3,449,489
|
)
|
|
$
|
(1,522,309
|
)
|
|
•
|
John N. Hatsopoulos, the Company’s Chief Executive Officer who is also: (a) the Chief Executive Officer and a director of American DG Energy and holds
10.7%
of American DG Energy’s common stock; (b) the Chairman of EuroSite Power; (c) a director of Ilios and holds
7.2%
of EuroSite Power’s common stock; and (d) the Chairman of GlenRose Instruments and holds
15.7%
of GlenRose Instruments’ common stock.
|
|
•
|
Dr. George N. Hatsopoulos, who is John N. Hatsopoulos’ brother, and is also: (a) a director of American DG Energy and holds
13.6%
of American DG Energy’s common stock; (b) an investor in Ilios and holds
3.1%
of Ilios' common stock; (c) an investor of GlenRose Instruments and holds
15.7%
of GlenRose Instruments' common stock; (d) an investor of Pharos and may be deemed to hold
24.4%
of Pharos' common stock; and (e) an investor of Levitronix and may be deemed to hold
21.4%
of Levitronix’s common stock.
|
|
•
|
Barry J. Sanders, who is: (a) the President and Chief Operating Officer of American DG Energy, (b) the Chief Executive Officer and a director of EuroSite Power and (c) the Chairman of Ilios.
|
|
•
|
Anthony S. Loumidis, the Company’s former Vice President and Treasurer who is: (a) the former Chief Financial Officer Secretary and Treasurer of American DG Energy, (b) the former Chief Financial Officer Secretary and Treasurer of EuroSite Power, (c) the former Chief Financial Officer Secretary and Treasurer of GlenRose Instruments and (d) the former Treasurer of Ilios.
|
|
|
December 31, 2012
|
|
Quoted
Prices
in Active
Markets
(Level 1)
|
|
Significant
Other
Observable
Inputs
(Level 2)
|
|
Significant
Unobservable
Inputs
(Level 3)
|
||||||||
|
Assets
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Certificates of deposit
|
181,859
|
|
|
—
|
|
|
181,859
|
|
|
—
|
|
||||
|
Total Assets
|
$
|
181,859
|
|
|
$
|
—
|
|
|
$
|
181,859
|
|
|
$
|
—
|
|
|
Inventory
|
|
$
|
17,400
|
|
|
Machinery and equipment
|
|
171,910
|
|
|
|
Computer equipment
|
|
22,070
|
|
|
|
Tooling
|
|
5,550
|
|
|
|
Developed technology
|
|
240,000
|
|
|
|
Goodwill
|
|
40,870
|
|
|
|
|
|
$
|
497,800
|
|
|
|
2013
|
|
2012
|
||||
|
Benefit at federal statutory tax rate
|
$
|
1,280,000
|
|
|
$
|
680,000
|
|
|
Unbenefited operating losses
|
(1,280,000
|
)
|
|
(680,000
|
)
|
||
|
Income tax provision
|
$
|
—
|
|
|
$
|
—
|
|
|
|
2013
|
|
2012
|
||||
|
Net operating loss carryforwards
|
$
|
4,850,000
|
|
|
$
|
3,380,000
|
|
|
Accrued expenses and other
|
598,000
|
|
|
676,000
|
|
||
|
Accounts receivable
|
40,000
|
|
|
60,000
|
|
||
|
Inventory
|
117,000
|
|
|
130,000
|
|
||
|
Property, plant and equipment
|
155,000
|
|
|
94,000
|
|
||
|
|
5,760,000
|
|
|
4,340,000
|
|
||
|
Valuation allowance
|
(5,760,000
|
)
|
|
(4,340,000
|
)
|
||
|
Net deferred tax asset
|
$
|
—
|
|
|
$
|
—
|
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|